0001209191-12-024325.txt : 20120426
0001209191-12-024325.hdr.sgml : 20120426
20120426153826
ACCESSION NUMBER: 0001209191-12-024325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120425
FILED AS OF DATE: 20120426
DATE AS OF CHANGE: 20120426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 12783322
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-04-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2012-04-25
4
M
0
4000
15.87
A
636895
D
Common Stock
2012-04-25
4
S
0
4000
37.72
D
632895
D
Common Stock
13286
I
401(k)
Common Stock
300000
I
Common Stock held in trust.
Stock Option
15.87
2012-04-25
4
M
0
4000
0.00
D
2012-07-21
Common Stock
4000
7314
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $37.72 (range $37.28 to $38.03).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Common stock held in grantor retained annuity trusts.
Fully vested.
David T. Howton, Attorney-In-Fact
2012-04-26